CDNA

<b>CareDx, Inc.</b> (NASDAQ:CDNA) is a precision medicine company that specializes in diagnostic solutions for organ transplant patients and their healthcare providers. Founded in 1998 and originally known as XDx, Inc., the company changed its name to CareDx in March 2014 and went public the same year. Headquartered in South San Francisco, California, CareDx has established itself as a leader in transplant diagnostics, developing innovative testing solutions that help monitor organ transplant rejection and optimize patient outcomes. The company serves transplant centers, laboratories, and patients worldwide through a comprehensive portfolio of diagnostic tests, digital health solutions, and laboratory products.